Overview

Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer

Status:
Recruiting

Trial end date:
2023-10-31

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to compare Hyperthermic Intraperitoneal Chemotherapy combined with Chemotherapy and Chemotherapy as a conversion therapy for gastric Cancer Patients with peritoneal metastasis in Safety and Effectiveness.

Phase:

N/A

Details

Lead Sponsor:

Tianjin Medical University Cancer Institute and Hospital

Treatments:

Paclitaxel